Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy

Siraj M. Ali, R. Katherine Alpaugh, Sean R. Downing, Philip J. Stephens, Jian Q. Yu, Hong Wu, Jamie K. Buell, Vincent A. Miller, Doron Lipson, Gary A. Palmer, Jeffrey S. Ross, Massimo Cristofanilli

Research output: Contribution to journalComment/debate

32 Scopus citations
Original languageEnglish (US)
Pages (from-to)e88-e91
JournalJournal of Clinical Oncology
Volume32
Issue number25
DOIs
StatePublished - Sep 1 2014

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Ali, S. M., Alpaugh, R. K., Downing, S. R., Stephens, P. J., Yu, J. Q., Wu, H., Buell, J. K., Miller, V. A., Lipson, D., Palmer, G. A., Ross, J. S., & Cristofanilli, M. (2014). Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy. Journal of Clinical Oncology, 32(25), e88-e91. https://doi.org/10.1200/JCO.2013.49.0599